Manufacturing B BioProcess International
Extended reality in bioprocessing hinges on QA/QC acceptance
An industry paper argues that the first company to make quality-acceptable extended reality (XR) records will own the market.
The latest biotech and pharma news from the trade press, updated every hour and linked straight to the publisher. Follow funding, clinical, deals and more. Every story links straight to its publisher.
Manufacturing B BioProcess International
An industry paper argues that the first company to make quality-acceptable extended reality (XR) records will own the market.
Industry
C&EN Pharmaceuticals
Here’s what we’re watching in the chemical and pharmaceutical industries this week
Manufacturing B BioProcess International
Research
Medical Design and Outsourcing
Researchers at MIT have found that listening to certain sounds during parts of the sleep cycle can stimulate the flow of cerebrospinal fluid (CSF), helping the brain to clear out cellular debris. That includes waste products like lactic acid and potentially harmful proteins such…
Industry
Drug Delivery Business
Dexcom‘s (Nasdaq:DXCM) C-suite is seeing another of its members take on multiple roles. Its chief financial officer will now also serve as chief operating officer. Jereme Sylvain joined the diabetes tech company in 2018, and has been its CFO and executive VP since 2021. His new C…
Manufacturing B BioProcess International
AI has played a significant role in the creation and delivery of mRNA technology. Intismeran, the melanoma cancer therapy from Merck and Moderna, is no exception.
Funding P PLOS Biology
by Chuanying Niu, Xiaohan Huang, Qihong Yan, Banghui Liu, Xijie Gao, Yidong Song, Jingjing Wang, Longyu Wang, Zimu Li, Huiran Zheng, Ping He, Xiaodong Huang, Hang Yuan, Binqian Zou, Yuedong Yang, Fandi Wu, Yicheng Yao, Gul Habib, Xinwen Chen, Ling Chen, Jun He, Jianhua Yao, Jincu…
Industry P PLOS Biology
by Sabine Grüschow, Peter Wotherspoon, Emma Hilton-Balfe, Shirley Graham, Malcolm F. White Cyclic nucleotide second messengers are used in all domains of life to amplify viral infection signals and activate cellular defences. In prokaryotes, CBASS (cyclic nucleotide-based antipha…
Industry P PLOS Biology
by Felipe Valença-Pereira, Bryan Johnson, James DeGregori, Mercedes Rincon Chronic infections are associated with cancer incidence and progression in human epidemiological data, but less is known about how such infections might promote cancer progression. Recent data implicate ac…
Regulatory
FDA Press Announcements
The U.S. Food and Drug Administration today announced the final design of the Expedited Investigational New Drug (IND) Pilot.
Industry
MedCity News
Pharma leaders must take a “construction crew” mindset and start treating workforce development in the same manner as they do critical infrastructure. The post The Real Bottleneck in U.S. Pharma Reshoring Isn’t Factories – It’s Talent appeared first on MedCity News.
Regulatory
Drug Delivery Business
Beta Bionics (NASDAQ: BBNX) has claimed an FDA clearance for its first patch pump insulin delivery system, amid plans to roll out an updated diabetes dosing algorithm and the launch of a new CGM partnership with Senseonics. The three-day, wearable Mint carries a 200-unit insulin…
Software P Pistoia Alliance
From junkyard to online store: the FAIR Maturity Matrix gives your organization a common language to measure, communicate and improve your FAIR data journey. What it is, how it works, and how to use it. The post Is Your Organization a Data Junkyard or a Data Marketplace? appeared…
Industry T The Labs Report
For centuries, we accepted resource trade-offs as laws of nature — workarounds for our inability to see biology clearly. Now we can design ecosystems that turn that sight into solutions.
Software W Weekly Bioinformatics
EBV isn't harmless, and vector search can't bridge complex literature. How a 172-kb genome hacks human immunity—and how a 700k-edge knowledge graph maps the gap.
Manufacturing B BioProcess International
Experts describe how mRNA represents a promising tool against one of nature’s oldest diseases.
Industry F FDA Law Blog
By Abdie Santiago & Jeffrey N. Wasserstein & Anne K. Walsh —
Industry
BioCentury
BIOCENTURY | FINANCELAZARD’S GLUCKMAN: ANNUAL SURVEY HINTS AT ‘CHANGE IN ARCHITECTURE’ ACROSS INDUSTRYBiopharma leaders’ responses suggest optimism is on the rise, as factors ‘redraw’ how drugs are created, developed, and brought to market
Regulatory
MHRA
The MHRA has reaffirmed its commitment to strengthening regulatory collaboration with Malaysia following high-level discussions in Kuala Lumpur.
Industry
Medical Design and Outsourcing
Epicenter has selected five medtech startups to participate in its ZeroTo510 Accelerator, which supports early-stage medtech founders accelerating toward commercialization. Epicenter is a Memphis-based nonprofit that helps startups grow their ventures. Its ZeroTo510 Accelerator i…
Agriculture E European Seed
Sunshine tomato, a precision-bred crop enriched with pro-vitamin D3, has passed a key regulatory milestone in England. Researchers say the biofortified tomato could support public health while moving closer to commercial sale. The post One Tomato. Two Eggs’ Worth of Vitamin D? ap…
Industry I In the Pipeline
Edit: the RSS feeds are back! I don't know why this couldn't have been done when the new web page designs rolled out, but you can find the feed addresses here. I'm also not sure why no one there got around to telling me (and many others) about this, but I am glad to have the func…
Regulatory
BioCentury
BIOCENTURY | REGULATIONPSYCHEDELICS AT FDA, MIKE DAVIS’ CDER AND TRANSLATING TRNAS — A BIOCENTURY PODCAST FDA could approve psychedelics before redosing is resolved. Plus: Takeaways from first interview by FDA’s new head of CDER
Industry
BioCentury
BIOCENTURY | PRODUCT DEVELOPMENTAZ’S CAMIZESTRANT MISS NARROWS ORAL SERD TREATMENT SETTINGSBioCentury’s Clinical Report Sept. 9-14
Software W Weekly Tech+Bio
ALSO: Scoring 9 billion DNA variants, agents in drug discovery stack, repurposing for cheap indications, whole-brain connectomics, brain-computer interfaces, and more...
Industry C Cell Systems
Darmawan et al. introduce multi-mutant sampling strategies for protein language models that exploit epistatic interactions, together with a holistic in silico evaluation framework scoring relevance, quality, and diversity. Benchmarked across diverse protein fitness landscapes, th…
Software
Ground Truths
A conversation with Prof Marios Georgakis
Industry
Medical Design and Outsourcing
While every medical device company celebrates clearances, some cleared devices never get used. Clearance guarantees nothing about whether a device ever reaches a patient, a surgeon schedules the case or a hospital covers the cost. The world’s largest medical device company puts f…
Industry
C&EN Pharmaceuticals
Software T This Week in Cheminformatics
CTMD, BONAFIDE and a long list of papers
Regulatory
MedCity News
Scholar Rock’s Isembyld isn’t the only FDA-approved therapy for spinal muscular atrophy, but it is the first one that directly targets muscle tissue. Isembyld is the first commercial product for Scholar Rock, which is also evaluating the antibody in other rare muscle disorders. T…
Industry
Medical Design and Outsourcing
My name is Conor Hale, and I’m happy to introduce myself as Medical Design & Outsourcing and MassDevice‘s new senior editor. I’ve had the pleasure of covering medical technology and the life sciences for the past 15 years at outlets including the Cancer Letter and FDAnew…
Industry
Drug Delivery Business
Medtronic (NYSE: MDT) is entering the final stretch of its long-running plan to split from its diabetes technology business, with the launch of an exchange offer that will allow stockholders to swap their company shares for those of the independent MiniMed (Nasdaq: MMED). With it…
Industry S SecureBio
We report findings from our pre-deployment assessment of the biological and biosecurity-relevant capabilities of GPT-6 Astra.
Agriculture E European Seed
Ukraine GMO law will introduce a broader framework for genetic engineering, GMO registration, labelling, traceability and enforcement. For the seed sector, the reset raises practical questions about implementation, crop restrictions and future alignment with EU rules. The post Uk…
Software C ChEMBL-og
We're excited to announce a new feature on ChEMBL compound pages: an interactive 3D viewer showing a low-energy, quantum-mechanically informed conformer for each compound, wherever one is available. This is part of a collaboration with the Isayev Lab at Carnegie Mellon University…
Software C ChEMBL-og
Thank you to everyone who has shared feedback with us through our UX studies and conversations with the ChEMBL team. Your input has helped us understand what’s working well, what could be smoother, and where small changes could make a big difference. Based on that feedback, we’ve…
Agriculture
Global Ag Tech Initiative
Taranis uses AI-powered crop intelligence to detect field threats, quantify yield impacts, and help agronomists make faster, more confident decisions. The post AI Crop Intelligence: From the Leaf to the Bottom Line appeared first on Global Ag Tech Initiative.
Industry P Practical Fragments
NLRP3 has received considerable attention as an inflammatory disease target. The protein normally exists in an auto-inhibited conformation, but in response to various stimuli it changes shape to help form a multimeric complex called the inflammasome. This in turn activates variou…
Software C ChEMBL-og
The Chemical Biology Resources Team at the European Bioinformatics Institute (EMBL-EBI) is looking for a talented Scientist with a flair for data curation to be responsible for the quality of bioactivity and drug discovery data in the ChEMBL database.ChEMBL is a world-leadi…